Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

UPM-Kymmene Corporation: Managers’ Transactions (Pesonen)

UPM-Kymmene Corporation        Managers’ Transactions                21 February 2022 at 16:00 EET UPM-Kymmene Corporation: Managers’ Transactions (Pesonen) UPM-Kymmene Corporation has on 21 February 2022 received the following notification:    ____________________________________________ Person subject to the notification requirementName: Pesonen, JussiPosition: Chief Executive OfficerIssuer: UPM-Kymmene CorporationLEI: 213800EC6PW5VU4J9U64 Notification type: INITIAL NOTIFICATION____________________________________________ Transaction date: 2022-02-21Venue not

UPM-Kymmene Corporation: Managers’ Transactions (Korpeinen)

UPM-Kymmene Corporation        Managers’ Transactions                21 February 2022 at 16:00 EET UPM-Kymmene Corporation: Managers’ Transactions (Korpeinen) UPM-Kymmene Corporation has on 21 February 2022 received the following notification:    ____________________________________________ Person subject to the notification requirementName: Korpeinen, TapioPosition: Chief Financial OfficerIssuer: UPM-Kymmene CorporationLEI: 213800EC6PW5VU4J9U64 Notification type: INITIAL NOTIFICATION____________________________________________ Transaction date: 2022-02-21Venue

UPM-Kymmene Corporation: Managers’ Transactions (Kekki)

UPM-Kymmene Corporation        Managers’ Transactions                21 February 2022 at 16:00 EET UPM-Kymmene Corporation: Managers’ Transactions (Kekki) UPM-Kymmene Corporation has on 21 February 2022 received the following notification:    ____________________________________________ Person subject to the notification requirementName: Kekki, MikaPosition: Other senior managerIssuer: UPM-Kymmene CorporationLEI: 213800EC6PW5VU4J9U64 Notification type: INITIAL NOTIFICATION____________________________________________ Transaction date: 2022-02-21Venue not

UPM-Kymmene Corporation: Managers’ Transactions (Nikkilä)

UPM-Kymmene Corporation        Managers’ Transactions                21 February 2022 at 16:00 EET UPM-Kymmene Corporation: Managers’ Transactions (Nikkilä) UPM-Kymmene Corporation has on 21 February 2022 received the following notification:    ____________________________________________ Person subject to the notification requirementName: Nikkilä, JaakkoPosition: Other senior managerIssuer: UPM-Kymmene CorporationLEI: 213800EC6PW5VU4J9U64 Notification type: INITIAL NOTIFICATION____________________________________________ Transaction date: 2022-02-21Venue not

UPM-Kymmene Corporation: Managers’ Transactions (Jääskeläinen)

UPM-Kymmene Corporation        Managers’ Transactions                21 February 2022 at 16:00 EET UPM-Kymmene Corporation: Managers’ Transactions (Jääskeläinen) UPM-Kymmene Corporation has on 21 February 2022 received the following notification:    Person subject to the notification requirementName: Jääskeläinen, AnttiPosition: Other senior managerIssuer: UPM-Kymmene CorporationLEI: 213800EC6PW5VU4J9U64 Notification type: INITIAL NOTIFICATION____________________________________________ Transaction date: 2022-02-21Venue not applicableInstrument type: SHAREISIN:

UPM-Kymmene Corporation: Managers’ Transactions (Eikens)

UPM-Kymmene Corporation        Managers’ Transactions                21 February 2022 at 16:00 EET UPM-Kymmene Corporation: Managers’ Transactions (Eikens)  UPM-Kymmene Corporation has on 21 February 2022 received the following notification:    ____________________________________________ Person subject to the notification requirementName: Eikens, BerndPosition: Other senior managerIssuer: UPM-Kymmene CorporationLEI: 213800EC6PW5VU4J9U64 Notification type: INITIAL NOTIFICATION____________________________________________ Transaction date: 2022-02-21Venue not

Norwegian Green Platform Initiative to Support Sustainable Battery Production

New York, Oslo and Luxembourg, February 21, 2022, FREYR Battery (NYSE: FREY) (“FREYR”), a developer of clean, next-generation battery cell production, is announcing that the Research Council of Norway, Innovation Norway, and Siva have granted $11 million (NOK 100 million) through the Norwegian Green Platform initiative (the “Green Platform”) to a consortium of companies, including FREYR. The initiative is intended to provide a platform to establish sustainable battery production. The consortium of companies will, together with SINTEF and the Institute for Energy Technology, initiate the

Notice to the Annual General Meeting of Citycon Oyj

Citycon Oyj   Stock Exchange Release   21 February 2022 at 15:05 hrsThe Annual General Meeting of Citycon Oyj will be held on Tuesday, 22 March 2022 at 12:00 noon. The meeting will be held under special arrangements without shareholders’ or their proxy representatives’ presence at the headquarters of Citycon Oyj, at the address Piispansilta 9 A, FI-02230 Espoo, Finland.The Board of Directors of Citycon Oyj has resolved on exceptional meeting procedures based on the temporary legislative act to limit the spread of the Covid-19 pandemic (375/2021). In order to ensure the health and safety

Kojamo Plc: Managers` Transactions

Kojamo Plc Stock Exchange Release, 21 February 2022 at 3:05 p.m. EETKojamo Oyj - Managers' Transactions Person subject to the notification requirement Name: Jani Nieminen Position: Chief Executive Officer Issuer: Kojamo Oyj LEI: 7437007YPUOQZ8OV1R42 Notification type: INITIAL NOTIFICATION Reference number: 10341/5/4 ____________________________________________ Transaction date: 2022-02-17 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: SHARE ISIN: FI4000312251 Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction details (1)

Kojamo Plc: Managers` Transactions

Kojamo Plc Stock Exchange Release, 21 February 2022 at 3:04 p.m. EETKojamo Oyj - Managers' Transactions Person subject to the notification requirement Name: Erik Hjelt Position: Chief Financial Officer Issuer: Kojamo Oyj LEI: 7437007YPUOQZ8OV1R42 Notification type: INITIAL NOTIFICATION Reference number: 10362/6/4 ____________________________________________ Transaction date: 2022-02-17 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: SHARE ISIN: FI4000312251 Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction details (1):

Scandinavian ChemoTech's co-founder Göran Hellers has passed away

It is with great sadness that we announce that the Company's co-founder, former board member and our friend, Göran Hellers, has died after a short illness.“With great sadness in my heart, I have today received information that my friend and co-founder of ChemoTech has passed away. Since we met 10 years ago, Dr Göran has been an extremely knowledgeable and driven colleague who, alongside me, launched the first generation of electroporation in Asia, Africa and South America. It was during those years that Göran and I saw the shortcomings of the older electroporation method and realized that

Kojamo Plc: Managers` Transactions

Kojamo Plc Stock Exchange Release, 21 February 2022 at 3:03 p.m. EETKojamo Oyj - Managers' Transactions Person subject to the notification requirement Name: Ville Raitio Position: Other senior manager Issuer: Kojamo Oyj LEI: 7437007YPUOQZ8OV1R42 Notification type: INITIAL NOTIFICATION Reference number: 10372/5/4 ____________________________________________ Transaction date: 2022-02-17 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: SHARE ISIN: FI4000312251 Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction details (1):

Kojamo Plc: Managers` Transactions

Kojamo Plc Stock Exchange Release, 21 February 2022 at 3:02 p.m. EETKojamo Oyj - Managers' Transactions Person subject to the notification requirement Name: Tiina Kuusisto Position: Other senior manager Issuer: Kojamo Oyj LEI: 7437007YPUOQZ8OV1R42 Notification type: INITIAL NOTIFICATION Reference number: 10369/5/4 ____________________________________________ Transaction date: 2022-02-17 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: SHARE ISIN: FI4000312251 Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction details (1):

Kojamo Plc: Managers` Transactions

Kojamo Plc Stock Exchange Release, 21 February 2022 at 3:01 p.m. EETKojamo Oyj - Managers' Transactions Person subject to the notification requirement Name: Irene Kantor Position: Other senior manager Issuer: Kojamo Oyj LEI: 7437007YPUOQZ8OV1R42 Notification type: INITIAL NOTIFICATION Reference number: 10366/5/4 ____________________________________________ Transaction date: 2022-02-17 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: SHARE ISIN: FI4000312251 Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction details (1):

BEWI ASA – Approval of prospectus for listing of shares in connection with acquisition of Jackon

Reference is made to the stock exchange announcement published by BEWI ASA ("BEWI" or the "Company") on 1 October 2021 regarding its offer to acquire all shares in Jackon Holding AS ("Jackon") and the announcement published on 15 October 2021 where it was announced that HAAS AS, an owner of 50 per cent of the shares in Jackon, had accepted the offer and chosen to receive its consideration in the form of 32,070,000 new shares in BEWI (the "Consideration Shares"). Reference is further made to the extraordinary general meeting held on 16 February 2022, where the Company's shareholders resolved

Kojamo Plc: Managers` Transactions

Kojamo Plc Stock Exchange Release, 21 February 2022 at 3:00 p.m. EETKojamo Oyj - Managers' Transactions Person subject to the notification requirement Name: Katri Harra-Salonen Position: Other senior manager Issuer: Kojamo Oyj LEI: 7437007YPUOQZ8OV1R42 Notification type: INITIAL NOTIFICATION Reference number: 10365/5/4 ____________________________________________ Transaction date: 2022-02-17 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: SHARE ISIN: FI4000312251 Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction details

CapMan’s Annual Report for 2021 published

CapMan Plc Stock Exchange Release / Annual Financial Report21 February 2022 at 15:00 EET CapMan’s Annual Report for 2021 published CapMan has published its Annual Report for 2021 on its website at www.capman.com/annual-reports/. The report includes the Report of the Board of Directors, the Group Financial Statements, the Auditor’s Report and the Corporate Governance Statement. CapMan also publishes the Annual Report in accordance with European Single Electronic Format (ESEF) reporting requirements with the format of the report being Extensible Hypertext Markup Language (xHTML).

Fiskars’ Annual Report 2021 published

Fiskars CorporationStock Exchange ReleaseFebruary 21, 2022 at 15.00 (EET) Fiskars’ Annual Report 2021 published Fiskars Corporation has today published its Annual Report for the year 2021. The Annual Report 2021 consists of the Board of Director’s report, the Financial Statements and the Auditor’s report, the Corporate Governance Statement, the Remuneration Statement and the Sustainability report. All of the above statements are attached to this release and are also available on Fiskars’ website at https://fiskarsgroup.com/investors/reports-and-presentations/annual-and-interim-

Healthcare heavyweight joins Cardo Health on its mission to improve the health of millions of people in emerging markets as co-founder and deputy CEO

Masha Feigelman is joining Cardo Health as co-founder and deputy CEO. She is a former partner at McKinsey (20+ years) where she built and scaled the European start-up and healthcare practises including setting up Russia's McKinsey healthcare practice.  Throughout her career Masha has supported organisational transformation and built new business, including service lines for McKinsey. Since leaving McKinsey in 2020 Masha has advised and coached multiple digital health start-ups and scaleups on strategic and organisational topics - from international expansion to OKR implementation. Masha is

Aptahem reports additional positive biological effect in a Corona virus-induced acute lung injury model treated with Apta-1

Aptahem can today announce that in addition to previously reported positive preliminary data, the Toronto team has, from further studies, found essential positive effects in a Corona virus challenge induced Acute Lung Injury model with Apta-1 treatment. Studies show that Apta-1 preliminary protects and recovers the lung tissue, significantly reduce the virus count and hemolysis, plus improves the clinical markers for the liver and kidneys. Previous studies show that Apta-1 supports and maintains systemic circulation, which is crucial to keeping the organism vital.Research commissioned by

Terrafame Ltd publishes its full year 2021 result on 4 March 2022

MEDIA RELEASE Terrafame Ltd publishes its full year 2021 result on Friday 4 March 2022 approximately at 09.00 a.m. Finnish time (please note the changed date). The report will be available on the company’s website at www.terrafame.com after publishing. Webcast briefing in Finnish for media representatives will be held on the same day at 01:00 p.m. Finnish time. In the briefing the result will be presented by Terrafame Ltd’s CEO Joni Lukkaroinen and Chief Financial Officer Ville Sirviö. The webcast can be viewed at terrafame.videosync.fi/tammi-joulukuu-2021. Questions can be asked by

Correction: DAMPSKIBSSELSKABET NORDEN A/S – WEEKLY REPORT ON SHARE BUY-BACK

ANNOUNCEMENT NO. 46 - 21 FEBRUARY 2022 On 4 November 2021, NORDEN initiated a share buy-back programme in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and Commission Delegated Regulation (EU) 2016/1052, (Safe Harbour regulation). The share buy-back programme runs from 4 November 2021 up to and including no later than end February 2022. For details, please see announcement no. 75 of 4 November 2021. Under the share buy-back programme, NORDEN will purchase shares for up to a total of USD 40 million (approximately DKK 263 million).

The scientific article "Bioconjugation of photon-upconversion nanoparticles for cancer biomarker detection and imaging" is now published in the scientific journal Nature Protocols

The scientific article entitled "Bioconjugation of photon-upconversion nanoparticles for cancer biomarker detection and imaging" is now published in the scientific journal Nature Protocols. Read the article here.    Dr. Matthias Mickert, Senior Chemical Engineer at Lumito, was part of the Gorris group at the University of Regensburg, which

There are no items matching the current filter
There are no more items matching the current filter
Back to top